Welcome Guest Log In  |  Sign Up
29 search results for SARS
# SuperPathway Name Genes Count Relevance Score
1 SARS-CoV-2 Infection 414 1.527
SuperPathway
  • SARS-CoV-2 Infection
Pathways
  • SARS-CoV-2 Infection
  • SARS-CoV-2-host interactions
  • SARS-CoV Infections
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
2 SARS-CoV-2 Genome Replication and Transcription 4 1.527
SuperPathway
  • SARS-CoV-2 Genome Replication and Transcription
Pathways
  • Replication of the SARS-CoV-1 genome
  • Replication of the SARS-CoV-2 genome
  • SARS-CoV-2 Genome Replication and Transcription
  • SARS-CoV-1 Genome Replication and Transcription
3 SARS-CoV-1-host interactions 142 1.527
SuperPathway
  • SARS-CoV-1-host interactions
Pathways
  • SARS-CoV-1 activates/modulates innate immune responses
  • SARS-CoV-1 Infection
  • SARS-CoV-1-host interactions
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
4 Early SARS-CoV-2 Infection Events 83 1.394
SuperPathway
  • Early SARS-CoV-2 Infection Events
Pathways
  • SARS-CoV-1 Infection
  • Early SARS-CoV-2 Infection Events
  • SARS-CoV-2 Infection
5 SARS-CoV-2 modulates host translation machinery 53 1.236
SuperPathway
  • SARS-CoV-2 modulates host translation machinery
Pathways
  • SARS-CoV-2 modulates host translation machinery
  • SARS-CoV-1 modulates host translation machinery
6 Network map of SARS-CoV-2 signaling pathway 48 1.236
SuperPathway
  • Network map of SARS-CoV-2 signaling pathway
Pathways
  • Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex
  • Network map of SARS-CoV-2 signaling pathway
7 SARS-CoV-2 targets PDZ proteins in cell-cell junction 4 1.236
SuperPathway
  • SARS-CoV-2 targets PDZ proteins in cell-cell junction
Pathways
  • SARS-CoV-2 targets PDZ proteins in cell-cell junction
  • SARS-CoV-1 targets PDZ proteins in cell-cell junction
8 Mitochondrial immune response to SARS-CoV-2 30 1.236
SuperPathway
  • Mitochondrial immune response to SARS-CoV-2
Pathways
  • SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction
  • Mitochondrial immune response to SARS-CoV-2
9 SARS-CoV-2 altering angiogenesis via NRP1 5 1.030
SuperPathway
  • SARS-CoV-2 altering angiogenesis via NRP1
Pathways
  • SARS-CoV-2 altering angiogenesis via NRP1
10 Activation of NLRP3 inflammasome by SARS-CoV-2 7 1.030
SuperPathway
  • Activation of NLRP3 inflammasome by SARS-CoV-2
Pathways
  • Activation of NLRP3 inflammasome by SARS-CoV-2
11 Extrafollicular B cell activation by SARS-CoV-2 71 1.030
SuperPathway
  • Extrafollicular B cell activation by SARS-CoV-2
Pathways
  • Extrafollicular B cell activation by SARS-CoV-2
12 Soluble ACE2-mediated cell entry of SARS-CoV-2 4 1.030
SuperPathway
  • Soluble ACE2-mediated cell entry of SARS-CoV-2
Pathways
  • Soluble ACE2-mediated cell entry of SARS-CoV-2
13 SARS-CoV-2 modulates autophagy 11 1.030
SuperPathway
  • SARS-CoV-2 modulates autophagy
Pathways
  • SARS-CoV-2 modulates autophagy
14 Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway 30 1.030
SuperPathway
  • Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
Pathways
  • Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
15 SARS-CoV-2 innate immunity evasion and cell-specific immune response 51 1.030
SuperPathway
  • SARS-CoV-2 innate immunity evasion and cell-specific immune response
Pathways
  • SARS-CoV-2 innate immunity evasion and cell-specific immune response
16 Hijack of ubiquitination by SARS-CoV-2 12 1.030
SuperPathway
  • Hijack of ubiquitination by SARS-CoV-2
Pathways
  • Hijack of ubiquitination by SARS-CoV-2
17 Potential therapeutics for SARS 99 1.030
SuperPathway
  • Potential therapeutics for SARS
Pathways
  • Potential therapeutics for SARS
18 T-cell activation SARS-CoV-2 116 1.030
SuperPathway
  • T-cell activation SARS-CoV-2
Pathways
  • T-cell activation SARS-CoV-2
19 SARS-CoV-2 replication organelle formation 6 1.030
SuperPathway
  • SARS-CoV-2 replication organelle formation
Pathways
  • SARS-CoV-2 replication organelle formation
20 SARS-CoV-2 and COVID-19 pathway 10 1.030
SuperPathway
  • SARS-CoV-2 and COVID-19 pathway
Pathways
  • SARS-CoV-2 and COVID-19 pathway
21 Host-pathogen interaction of human coronaviruses - interferon induction 52 0.703
Pathways
  • Type I interferon induction and signaling during SARS-CoV-2 infection
  • SARS coronavirus and innate immunity
22 ACE Inhibitor Pathway, Pharmacodynamics 35 0.703
Pathways
  • SARS-CoV-2 and ACE2 receptor: molecular mechanisms
  • Downregulation of ACE2 by SARS-CoV-2 spike protein
23 Translation factors 50 0.497
Pathways
  • nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell
24 Immune response Function of MEF2 in T lymphocytes 124 0.497
Pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
25 DDX58/IFIH1-mediated induction of interferon-alpha/beta 110 0.497
Pathways
  • SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation
26 docosahexaenoate biosynthesis IV (4-desaturase, mammals) 16 0.497
Pathways
  • Linoleic acid metabolism affected by SARS-CoV-2
27 Translation Insulin regulation of translation 183 0.497
Pathways
  • Overview of perturbations to host-cell autophagy, induced by distinct proteins of SARS-CoV-2
28 Translation of Structural Proteins 70 0.497
Pathways
  • Late SARS-CoV-2 Infection Events
29 Death Receptor Signaling 119 0.497
Pathways
  • SARS-CoV-1-mediated effects on programmed cell death